Avalo Therapeutics, Inc. (AVTX)
19.35
+0.40
(+2.11%)
USD |
NASDAQ |
Sep 02, 16:00
19.35
0.00 (0.00%)
After-Hours: 17:53
Avalo Therapeutics Net Income (TTM) : -100.33M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -100.33M |
| March 31, 2026 | -84.74M |
| December 31, 2025 | -78.26M |
| September 30, 2025 | -99.88M |
| June 30, 2025 | -46.22M |
| March 31, 2025 | 73.01M |
| December 31, 2024 | -35.13M |
| September 30, 2024 | -7.958M |
| June 30, 2024 | -36.22M |
| March 31, 2024 | -142.88M |
| December 31, 2023 | -31.54M |
| September 30, 2023 | -33.19M |
| June 30, 2023 | -24.77M |
| March 31, 2023 | -29.56M |
| December 31, 2022 | -41.66M |
| September 30, 2022 | -50.98M |
| June 30, 2022 | -71.64M |
| March 31, 2022 | -75.83M |
| December 31, 2021 | -84.35M |
| September 30, 2021 | -81.36M |
| June 30, 2021 | -77.15M |
| March 31, 2021 | -72.80M |
| Date | Value |
|---|---|
| December 31, 2020 | -64.38M |
| September 30, 2020 | -51.17M |
| June 30, 2020 | -40.46M |
| March 31, 2020 | -32.79M |
| September 30, 2019 | -17.85M |
| June 30, 2019 | -39.53M |
| March 31, 2019 | -42.99M |
| December 31, 2018 | -41.71M |
| September 30, 2018 | -41.68M |
| June 30, 2018 | 1.642M |
| March 31, 2018 | 5.850M |
| December 31, 2017 | 7.773M |
| September 30, 2017 | 13.32M |
| June 30, 2017 | -11.57M |
| March 31, 2017 | -13.29M |
| December 31, 2016 | -16.47M |
| September 30, 2016 | -18.48M |
| June 30, 2016 | -13.00M |
| March 31, 2016 | -12.39M |
| December 31, 2015 | -10.49M |
| September 30, 2015 | -10.91M |
| June 30, 2015 | -13.84M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Incyte Corp. | 1.612B |
| AbbVie, Inc. | 6.274B |
| Rezolute, Inc. | -81.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |